All News
TIME Mag - "Why Masks Still Matter". 1) COVID is still out there; 2) Influenza on the rise. Authors write "With limited yet mixed data, we would be wise to ...err on the side of masking in high risk, indoor crowded public settings..." https://t.co/l8jiTwAdZz https://t.co/0QUKJDOhjs
Links:
Dr. John Cush RheumNow ( View Tweet)
1st quarter of 2022, only 29% of Medicaid and Medicare users had at least one telehealth visit - down from 46% in all of 2021. (Data from Centers for Medicare & Medicaid Services) https://t.co/RCYjlJOPS3
Dr. John Cush RheumNow ( View Tweet)
Will a vegetarian diet and exercise actually help RA disease activity?
At #ACR22, a Dutch program targeting a whole food plant-based diet, physical activity, and stress management has shown benefit in DAS28 RA disease activity measures.
https://t.co/W2axkmbs3y https://t.co/5jktGiEk0T
Links:
Dr. John Cush RheumNow ( View Tweet)
Open label trial compared arthroscopic repair to PT in 100 young pts w/ traumatic, MRI proven meniscal tear without knee OA. Outcomes at 24 months - both groups improvved and were not different between groups https://t.co/rbrUAWuKRa https://t.co/OaNTssAvCG
Links:
Dr. John Cush RheumNow ( View Tweet)
Medication adherence is a problem
I assume that when I prescribe something for patients that they fill the prescription (right away) and take it as planned…or is this a pipe dream?
@Janetbirdope weighs in.
https://t.co/qj3insA6fL https://t.co/yV0xlvdNZu
Links:
Dr. John Cush RheumNow ( View Tweet)
Does Evusheld shield people living with rheumatic diseases?
Dr. Yuz Yusof ( @Yuz6Yusof) discusses three key abstracts from #ACR22 on Evusheld findings.
https://t.co/wYl6Wpd5Fs https://t.co/7T7u4czNOX
Links:
Dr. John Cush RheumNow ( View Tweet)
A look back at #ACR22 Day 1.
https://t.co/UIZnquWAiU https://t.co/EZ2su56J5H
Links:
Dr. John Cush RheumNow ( View Tweet)
FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/6pMwBPFJJr https://t.co/lTdpX0FQwj
Links:
Dr. John Cush RheumNow ( View Tweet)
Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/vcvW8N11cm https://t.co/N5zx0I0lrn
Links:
Dr. John Cush RheumNow ( View Tweet)
Where are we with treating Pre-Rheumatoid Arthritis?
Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0530, #1603 and #1604 shared at #ACR22.
https://t.co/AagsZCyhSE https://t.co/K1RvdOMzvf
Links:
Dr. John Cush RheumNow ( View Tweet)
Spondyloarthritis Topic Panel - #ACR22
SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims
@synovialjoints @AkhilSoodMD @ericdeinmd @RHEUMarampa @DrCassySims
https://t.co/uFPW3NxZEm https://t.co/stjmhcFoaS
Links:
Dr. John Cush RheumNow ( View Tweet)
Women vs. Men: Response to Treatment in Seronegative Arthritis
Dr. Janet Pope ( @Janetbirdope) discusses abstracts 1614 and 1601 at #ACR22
https://t.co/nUFjPr1Zya https://t.co/L47pzS7YXv
Links:
Dr. John Cush RheumNow ( View Tweet)
Treatment Considerations in Axial Spondyloarthritis
Dr. Lianne Gensler discusses treatment considerations in Axial SpA from #ACR22.
-Abstract 0402
-Abstract 0388
-Abstract 0544
-Abstract 0545
https://t.co/1PvN3SnqHQ https://t.co/i2nyvjyv3D
Links:
Dr. John Cush RheumNow ( View Tweet)
Updates on Reproductive Health in Women with SLE
Dr. Catherine Sims ( @DrCassySims) summarizes reproductive health abstracts presented at #ACR22.
https://t.co/QxzoBWMexo https://t.co/4wUPKOOemE
Links:
Dr. John Cush RheumNow ( View Tweet)
Differences in Presentation and Outcomes of Early vs Late Onset PsA
Dr. Petryna ( @DrPetryna) discusses abstract 0377 presented at #ACR22. Abstract 0377: Differences in Early-onset vs. Late-onset PsA: Data from the RESPONDIA and REGISPONSER Studies
https://t.co/3dwYmx7Hva https://t.co/ZFlFmWRbMK
Links:
Dr. John Cush RheumNow ( View Tweet)
Potential new treatment for Sjogren's
Is there finally something new on the horizon in Sjogren’s syndrome?
Dr. Eric Dein. ( @ericdeinmd) discusses studies presented at #ACR22.
https://t.co/YinEPKlJb2 https://t.co/YOsc159GFt
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of #ACR22 Day 2 in PSA
-Efficacy and Safety Results from BE OPTIMAL in PsA
-JAK inhibitors in rheumatic diseases
-Who is the Winner? Switch vs Cycle in PsA
-Women vs. Men: Response to Treatment in Seronegative Arthritis
and more.
https://t.co/JSKafxioMT https://t.co/Ov0VuCdX5y
Links:
Dr. John Cush RheumNow ( View Tweet)
Topic Podcasts - PsA Part1
Best of PsA on Day 1 #ACR22
https://t.co/uXxUwy6u9G https://t.co/GDDXgcn2EC
Links:
Dr. John Cush RheumNow ( View Tweet)
SLE, Sex and STDs
Once in a while, I find an abstract at the American College of Rheumatology meeting that can potentially save lives and be implemented in practice now.
Dr. Dao ( @KDAO2011) discusses abstract #0939 presented at #ACR22.
https://t.co/0DtAgzB41G https://t.co/O1z7J0O4c6
Links:
Dr. John Cush RheumNow ( View Tweet)
TNFi cycling in axSpA: Results from CorEVITAS Registy study
Dr. Rachel Tate ( @uptotate) reviews abstract #1499 presented at #ACR22.
https://t.co/rvzB2RHkAD https://t.co/m3uiXAvZmZ
Links:
Dr. John Cush RheumNow ( View Tweet)
